Rapid Therapeutic Science Laboratories, Inc.
RTSL
$0.0074
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 46.40K | 191.30K | 48.90K | -227.10K | -36.80K |
| Total Depreciation and Amortization | 48.50K | 6.00K | -57.80K | 27.30K | 48.50K |
| Total Amortization of Deferred Charges | 53.00K | 30.30K | 122.70K | 298.40K | 715.10K |
| Total Other Non-Cash Items | -91.30K | -348.70K | -210.60K | -432.80K | -797.90K |
| Change in Net Operating Assets | -63.90K | 79.30K | -255.30K | 168.80K | 136.30K |
| Cash from Operations | -7.30K | -41.80K | -352.00K | -165.40K | 65.20K |
| Capital Expenditure | -- | -- | 315.60K | 0.00 | -319.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 315.60K | 0.00 | -319.60K |
| Total Debt Issued | -33.60K | 83.60K | 225.80K | 112.40K | 373.00K |
| Total Debt Repaid | -14.50K | -24.20K | -189.40K | -59.10K | -39.40K |
| Issuance of Common Stock | 40.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8.10K | 59.40K | 36.40K | 53.30K | 333.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.40K | 17.60K | 0.00 | -112.20K | 79.20K |